Letter in response to the article: Vitamin D concentrations and COVID-19 infection in UK biobank (Hastie et al.).
作者信息
Grant W B, McDonnell S L
机构信息
Sunlight, Nutrition, and Health Research Center, P.O. Box 641603, San Francisco, CA, 94164-1603, USA. Electronic address: http://www.sunarc.org/.
GrassrootsHealth, Encinitas, CA, 92024, USA.
出版信息
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):893-894. doi: 10.1016/j.dsx.2020.05.046. Epub 2020 Jun 13.
Abstract
摘要
相似文献
1
Letter in response to the article: Vitamin D concentrations and COVID-19 infection in UK biobank (Hastie et al.).对文章《英国生物银行中维生素D浓度与COVID-19感染》（哈斯蒂等人著）的回应信
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):893-894. doi: 10.1016/j.dsx.2020.05.046. Epub 2020 Jun 13.
2
Response to 'Vitamin D concentrations and COVID-19 infection in UK Biobank'.对“英国生物银行中维生素D浓度与COVID-19感染”的回应
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):777. doi: 10.1016/j.dsx.2020.05.049. Epub 2020 Jun 4.
3
Response to letter to the editor by Abhipsha Sur Roy and Amol Joshi regarding the article: 'Multimorbidity and SARS-CoV-2 infection in UK Biobank' (Chudasama et al.).对阿比普莎·苏尔·罗伊和阿莫尔·乔希就文章《英国生物银行中的多重疾病与SARS-CoV-2感染》（楚达萨马等人著）致编辑信的回复
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1281. doi: 10.1016/j.dsx.2020.06.034. Epub 2020 Jun 23.
4
Reply to letter of Davie et al. regarding the article: "Vitamin D concentrations and COVID-19 infection in UK Biobank" (Hastie et al.).对戴维等人就文章《英国生物银行中的维生素D浓度与新冠病毒感染》（哈斯蒂等人著）所写信件的回复。
Diabetes Metab Syndr. 2021 Mar-Apr;15(2):642. doi: 10.1016/j.dsx.2021.02.017. Epub 2021 Feb 12.
5
Letter to the editor in response to the article: "Vitamin D concentrations and COVID-19 infection in UK biobank" (Hastie et al.).致编辑的信：回应文章《英国生物银行中的维生素D浓度与COVID-19感染》（哈斯蒂等人著）
Diabetes Metab Syndr. 2021 Mar-Apr;15(2):643-644. doi: 10.1016/j.dsx.2021.02.016. Epub 2021 Feb 9.
6
Response to Comment on "ApoE e4e4 Genotype and Mortality With COVID-19 in UK Biobank" by Kuo et al.对Kuo等人对《英国生物银行中载脂蛋白E e4e4基因型与COVID-19死亡率》评论的回应
J Gerontol A Biol Sci Med Sci. 2020 Oct 15;75(11):2235-2236. doi: 10.1093/gerona/glaa198.
7
Comment on "ApoE e4e4 Genotype and Mortality With COVID-19 in UK Biobank" by Kuo et al.对郭等人所著的《英国生物银行中载脂蛋白E e4e4基因型与COVID-19死亡率》的评论
J Gerontol A Biol Sci Med Sci. 2020 Oct 15;75(11):2233-2234. doi: 10.1093/gerona/glaa202.
8
Response to 'Multimorbidity and SARS-CoV-2 infection in UK biobank'.对《英国生物银行中的多重疾病与SARS-CoV-2感染》的回应
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):969. doi: 10.1016/j.dsx.2020.06.033. Epub 2020 Jun 24.
9
ApoE e4e4 Genotype and Mortality With COVID-19 in UK Biobank.英国生物银行中载脂蛋白E e4e4基因型与COVID-19死亡率
J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):1801-1803. doi: 10.1093/gerona/glaa169.
10
SARS-CoV-2 severity in African Americans - A role for Duffy Null?非裔美国人中新型冠状病毒肺炎的严重程度——达菲阴性的作用？
Haematologica. 2020 Dec 1;105(12):2892. doi: 10.3324/haematol.2020.269415.
引用本文的文献
1
The Promise of AI in Detection, Diagnosis, and Epidemiology for Combating COVID-19: Beyond the Hype.人工智能在抗击新冠疫情中的检测、诊断和流行病学方面的前景：超越炒作。
Front Artif Intell. 2021 May 14;4:652669. doi: 10.3389/frai.2021.652669. eCollection 2021.
2
Dietary Supplements and Nutraceuticals under Investigation for COVID-19 Prevention and Treatment.正在接受新冠病毒预防和治疗研究的膳食补充剂与营养保健品
mSystems. 2021 May 4;6(3):e00122-21. doi: 10.1128/mSystems.00122-21.
3
New Roles for Vitamin D Superagonists: From COVID to Cancer.维生素 D 超强激动剂的新作用：从新冠到癌症。
Front Endocrinol (Lausanne). 2021 Mar 31;12:644298. doi: 10.3389/fendo.2021.644298. eCollection 2021.
4
Letter to the editor in response to the article: "Vitamin D concentrations and COVID-19 infection in UK biobank" (Hastie et al.).致编辑的信：回应文章《英国生物银行中的维生素D浓度与COVID-19感染》（哈斯蒂等人著）
Diabetes Metab Syndr. 2021 Mar-Apr;15(2):643-644. doi: 10.1016/j.dsx.2021.02.016. Epub 2021 Feb 9.
5
Dietary Supplements and Nutraceuticals Under Investigation for COVID-19 Prevention and Treatment.正在接受调查的用于预防和治疗新冠肺炎的膳食补充剂和营养保健品。
ArXiv. 2021 Feb 3:arXiv:2102.02250v1.
6
Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction - A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic.维生素D与新型严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）呼吸功能障碍之间的关联——当前证据的综述及其对2019冠状病毒病大流行的启示
Front Physiol. 2020 Nov 26;11:564387. doi: 10.3389/fphys.2020.564387. eCollection 2020.
7
Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity.有关维生素 D 与 COVID-19 风险及其严重程度的证据。
Nutrients. 2020 Oct 31;12(11):3361. doi: 10.3390/nu12113361.
8
A Basic Review of the Preliminary Evidence That COVID-19 Risk and Severity Is Increased in Vitamin D Deficiency.维生素 D 缺乏与 COVID-19 风险和严重程度增加相关的初步证据概述。
Front Public Health. 2020 Sep 10;8:513. doi: 10.3389/fpubh.2020.00513. eCollection 2020.
9
Nutritional status of micronutrients as a possible and modifiable risk factor for COVID-19: a UK perspective.微量营养素的营养状况可能是 COVID-19 的一个可改变的风险因素：英国的观点。
Br J Nutr. 2021 Mar 28;125(6):678-684. doi: 10.1017/S000711452000330X. Epub 2020 Aug 20.
10
Key Aspects in Nutritional Management of COVID-19 Patients.新型冠状病毒肺炎患者营养管理的关键要点
J Clin Med. 2020 Aug 10;9(8):2589. doi: 10.3390/jcm9082589.
本文引用的文献
1
Vitamin D concentrations and COVID-19 infection in UK Biobank.英国生物银行中的维生素D浓度与2019冠状病毒病感染情况
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):561-565. doi: 10.1016/j.dsx.2020.04.050. Epub 2020 May 7.
2
Maternal 25(OH)D concentrations ≥40 ng/mL associated with 60% lower preterm birth risk among general obstetrical patients at an urban medical center.在一家城市医疗中心的普通产科患者中，母亲25（羟基）维生素D浓度≥40纳克/毫升与早产风险降低60%相关。
PLoS One. 2017 Jul 24;12(7):e0180483. doi: 10.1371/journal.pone.0180483. eCollection 2017.
3
Collinearity and Causal Diagrams: A Lesson on the Importance of Model Specification.共线性与因果图：关于模型设定重要性的一课
Epidemiology. 2017 Jan;28(1):47-53. doi: 10.1097/EDE.0000000000000554.
4
Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology.因果知识作为混杂因素评估的先决条件：在出生缺陷流行病学中的应用
Am J Epidemiol. 2002 Jan 15;155(2):176-84. doi: 10.1093/aje/155.2.176.
Zotero 插件